EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Three‐year survival rate and prognostic factors among women with vulvar cancer treated at Ocean Road Cancer Institute in Tanzania: A retrospective cohort study

Noela J. Almada, Olola Oneko, Gileard Masenga, Blandina T. Mmbaga, David H. Mvunta, Yotham A. Gwanika, Joshua S. Mollel, Baraka J. Shao, Alex Mremi, Bariki Mchome

International Journal of Gynecology & Obstetrics · 2026-11-11

DOI: 10.1002/ijgo.71473 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objective Vulvar cancer accounts for approximately 5% of gynecologic malignancies worldwide. Global incidence remains low (0.85 per 100 000 women). Vulvar cancer is under‐reported in low‐ and middle‐income countries, and survival data from sub‐Saharan Africa remain limited. This study evaluates the 3‐year survival rate and associated prognostic factors among women diagnosed with vulvar cancer at Ocean Road Cancer Institute in Tanzania. Methods A retrospective cohort study of 127 women with histologically confirmed vulvar cancer diagnosed between January 2019 and December 2021 was conducted. Overall survival was estimated using the Kaplan–Meier method. Cox proportional hazards regression identified mortality predictors. Analyses were performed using STATA 17. Results Among 127 patients, 61.4% were aged >45 years and 62.2% were HIV‐positive. Squamous cell carcinoma (SCC) was the predominant histological subtype (89%). The 1‐, 2‐, and 3‐year survival rates were 76.0%, 51.3%, and 39.1%, respectively. In the univariate analysis, factors associated with mortality were age greater than 45 years ( P = 0.047), lymph node involvement ( P = 0.046), advanced FIGO (the International Federation of Gynecology & Obstetrics) stage ( P < 0.001), lack of surgical treatment ( P = 0.010), and suboptimal treatment ( P = 0.004) In multivariate analysis, advanced stage (adjusted hazard ratio, aHR = 2.93, P < 0.001) and suboptimal treatment (aHR = 1.91, P = 0.031) were independent predictors of mortality, with age greater than 45 years showing marginal significance (aHR = 1.62, P = 0.054). Conclusion Three‐year survival among women with vulvar cancer at Ocean Road Cancer Institute was poor (39.1%). SCC was the predominant histology. Advanced FIGO stage, older age, and suboptimal treatment independently predicted mortality.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →